4402-17-9

Basic information

• Product Name: Benzenamine, 4,4'-[5,5'-bi-1H-benzimidazole]-2,2'-diylbis-
• CAS NO: 4402-17-9
• Molecular Formula: C26H20N6
• Molecular Weight: 416.485
• Mol File: 4402-17-9.mol
• Article Data: 4

Chemical Properties

• Melting Point: 321-322 °C
• Boiling Point: 810.7±75.0 °C(Predicted)
• Density: 1.382±0.06 g/cm3(Predicted)
• CAS DataBase Reference: Benzenamine, 4,4'-[5,5'-bi-1H-benzimidazole]-2,2'-diylbis-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzenamine, 4,4'-[5,5'-bi-1H-benzimidazole]-2,2'-diylbis-(4402-17-9)
• EPA Substance Registry System: Benzenamine, 4,4'-[5,5'-bi-1H-benzimidazole]-2,2'-diylbis-(4402-17-9)

Safety Data

• Hazardous Substances Data: 4402-17-9(Hazardous Substances Data)

Upstream product

• 91-95-2 3,3',4,4'-tetraaminobiphenyl 
• 150-13-0 4-amino-benzoic acid 
• 144072-29-7 tert-butyl N-[4-(hydroxymethyl)phenyl]carbamate 
• 144072-30-0 4-((tert-butoxycarbonyl)amino)benzaldehyde 
• 623-04-1 4-aminobenzenemethanol 
• 887245-02-5 2,2-bis(4'-[N-(tert-butoxycarbonyl)amino]phenyl)-5,5-bi-1H-benzimidazole 

Downstream Products

• 887245-04-7 2,2-bis-(4'-[3''-chloropropanamido]phenyl)-5,5-bi-1H-benzimidazole 

Relevant articles and documents

BIS-BENZIMIDAZOLE COMPOUNDS AND METHODS OF USING SAME

Provided herein are compounds and methods for modulating abnormal repeat expansions of gene sequences. More particularly, provided are inhibitors of RNA and the uses of such inhibitors in regulating nucleotide repeat expansions, e.g., to treat Myotonic Dystrophy Type 1 (DM1 ), Myotonic Dystrophy Type 2 (DM2), Fuchs dystrophy, Huntington Disease, Amyotrophic Lateral Sclerosis, or Frontotemporal Dementia.

ANTIBACTERIAL COMPOUNDS

Disclosed are compounds of formula (I), which are of use in the treatment of bacterial diseases and infections, to compositions containing those compounds and to methods of treating bacterial diseases and infections using the compounds. In particular, the compounds are useful for the treatment of infection with, and diseases caused by, Clostridium difficile.